Advertisement
News
Subscribe to MDT Magazine News

Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference

October 15, 2010 8:34 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Oct. 15 /- Elekta will showcase updates to its Leksell GammaPlan® 10.0* treatment planning software for Leksell Gamma Knife® and the Extend™ program for Leksell Gamma Knife® Perfexion™ at the 2010 Congress of Neurological Surgeons (CNS) Annual...

TOPICS:

AACR Calls for SU2C Innovative Research Grant Letters of Intent

October 15, 2010 8:34 am | by AACR | Comments

PHILADELPHIA — The American Association for Cancer Research calls upon the cancer research community to submit Letters of Intent for Stand Up To Cancer’s Innovative Research Grants (IRG), which support the next generation of extraordinary cancer research leaders in their quest to conquer cancer.

TOPICS:

CDRH FOIA Electronic Reading Room (Added ReGen Biologics, Inc. Letter and Review Memo)

October 15, 2010 8:31 am | by U.S. Food & Drug Administration | Comments

Freedom of Information Act documents, in Adobe PDF format.

TOPICS:
Advertisement

Class I Medical Device Recall: CareFusion Corporation, Alaris PC Units (Model 8015)

October 15, 2010 8:30 am | by U.S. Food & Drug Administration | Comments

Reason for Recall: Under certain wireless network conditions, a communication error can occur, which freezes the PC Unit screen. This error may result in a delay of therapy and inability to make programming changes to current infusions...

TOPICS:

Leisureworld Announces October Dividend

October 15, 2010 5:45 am | by The Associated Press | Comments

Leisureworld Senior Care Corporation (TSX: LW) today announced that the Company's dividend for October, 2010 will be $0.0708 per share, representing $0.85 per share on an annualized basis. Payment will be made on November 15, 2010 to shareholders of record October 29, 2010.About...

EntreMed Receives Notice of NASDAQ Compliance

October 15, 2010 5:32 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Oct. 15 /- EntreMed, Inc. (Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum...

TOPICS:

Henry Schein to Webcast Third Quarter 2010 Conference Call Friday, October 29, at 10:00 a.m. EDT

October 15, 2010 5:32 am | by Bio-Medicine.Org | Comments

MELVILLE, N.Y., Oct. 15 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that it will release its third quarter 2010 financial results before the stock market opens on Friday, October 29, 2010,...

TOPICS:

Omeros to Present at the BioCentury NewsMakers Conference

October 15, 2010 5:32 am | by Bio-Medicine.Org | Comments

SEATTLE, Oct. 15 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief...

TOPICS:
Advertisement

Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®

October 15, 2010 4:31 am | by Bio-Medicine.Org | Comments

PITTSBURGH, Oct. 15 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50...

TOPICS:

Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery

October 15, 2010 3:31 am | by Bio-Medicine.Org | Comments

SHELBY TOWNSHIP, Mich., Oct 14 /- Allure Medical Spa, first in Michigan with the new FDA approved Coolsculpting™ by Zeltiq. Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby...

TOPICS:

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients

October 15, 2010 1:32 am | by Bio-Medicine.Org | Comments

Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients -- PARIS, October 15, 2010 /-

TOPICS:

Kibbutz Shamir and Essilor Sign Agreement

October 15, 2010 1:32 am | by Bio-Medicine.Org | Comments

Kibbutz Shamir and Essilor Sign Agreement -- KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, Oct. 15 /-

TOPICS:

Cellectis Publishes Its Financial Statement for the First Half of 2010

October 15, 2010 1:31 am | by Bio-Medicine.Org | Comments

PARIS, Oct. 15 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, today published its consolidated financial statement for the half-year ending June 30, 2010: revenues increased 25% over H1 2009, expenditure increased 50% and the company ended the period with euro...

TOPICS:

CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results

October 14, 2010 6:32 pm | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 14 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 third quarter financial results will be released on Thursday, November 4, 2010.  On that day, the Company will hold a...

TOPICS:

Henry Schein to buy Provet Holdings for $91M

October 14, 2010 5:45 pm | by The Associated Press | Comments

Henry Schein Inc. said Thursday it has agreed to buy Australian veterinary products distributor Provet Holdings Ltd. In a cash-for-stock deal valued at $91 million.Under the terms of the deal, Henry Schein will pay Provet shareholders $2.12 for each outstanding share, representing a premium of...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading